Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 60 | 2024 | 1184 | 14.110 |
Why?
|
Angioplasty, Balloon | 16 | 2024 | 653 | 6.050 |
Why?
|
Endovascular Procedures | 28 | 2024 | 1973 | 5.950 |
Why?
|
Femoral Artery | 28 | 2024 | 843 | 5.660 |
Why?
|
Drug-Eluting Stents | 19 | 2023 | 753 | 5.300 |
Why?
|
Popliteal Artery | 19 | 2024 | 317 | 3.740 |
Why?
|
Pulmonary Embolism | 22 | 2024 | 2370 | 3.630 |
Why?
|
Cardiovascular Agents | 7 | 2024 | 848 | 2.810 |
Why?
|
Paclitaxel | 19 | 2024 | 1707 | 2.570 |
Why?
|
Ultrasonography, Interventional | 9 | 2024 | 1483 | 2.540 |
Why?
|
Coated Materials, Biocompatible | 12 | 2024 | 319 | 2.180 |
Why?
|
Treatment Outcome | 105 | 2024 | 62966 | 1.910 |
Why?
|
Lower Extremity | 13 | 2023 | 1151 | 1.790 |
Why?
|
Medicare | 35 | 2023 | 6532 | 1.740 |
Why?
|
Coronary Artery Disease | 16 | 2023 | 6454 | 1.730 |
Why?
|
Platelet Aggregation Inhibitors | 17 | 2023 | 3067 | 1.620 |
Why?
|
Intermittent Claudication | 8 | 2023 | 309 | 1.560 |
Why?
|
Myocardial Infarction | 23 | 2023 | 11690 | 1.510 |
Why?
|
Endarterectomy, Carotid | 5 | 2023 | 546 | 1.440 |
Why?
|
Coronary Restenosis | 4 | 2022 | 424 | 1.430 |
Why?
|
Patient Readmission | 12 | 2021 | 3111 | 1.380 |
Why?
|
Carotid Stenosis | 5 | 2023 | 854 | 1.350 |
Why?
|
Vascular Surgical Procedures | 8 | 2023 | 1473 | 1.260 |
Why?
|
Stents | 18 | 2023 | 3276 | 1.260 |
Why?
|
Limb Salvage | 13 | 2024 | 433 | 1.220 |
Why?
|
Anticoagulants | 11 | 2023 | 4595 | 1.200 |
Why?
|
Ischemia | 13 | 2024 | 1911 | 1.190 |
Why?
|
Thrombosis | 7 | 2023 | 2966 | 1.190 |
Why?
|
United States | 66 | 2024 | 69693 | 1.120 |
Why?
|
Risk Factors | 73 | 2024 | 72145 | 1.110 |
Why?
|
Postoperative Hemorrhage | 3 | 2021 | 409 | 1.060 |
Why?
|
Hemorrhage | 17 | 2024 | 3461 | 1.000 |
Why?
|
Humans | 201 | 2024 | 742088 | 0.980 |
Why?
|
Aged | 84 | 2023 | 162944 | 0.970 |
Why?
|
Registries | 27 | 2023 | 8077 | 0.960 |
Why?
|
Hospital Mortality | 18 | 2023 | 5310 | 0.960 |
Why?
|
Coronary Occlusion | 4 | 2022 | 303 | 0.920 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2023 | 1384 | 0.900 |
Why?
|
Coronary Thrombosis | 6 | 2018 | 494 | 0.900 |
Why?
|
Pharmaceutical Preparations | 3 | 2022 | 1071 | 0.900 |
Why?
|
Healthcare Disparities | 8 | 2023 | 3151 | 0.890 |
Why?
|
Vascular Patency | 10 | 2023 | 885 | 0.880 |
Why?
|
Atherectomy | 4 | 2023 | 47 | 0.860 |
Why?
|
United States Social Security Administration | 1 | 2022 | 12 | 0.860 |
Why?
|
Pacemaker, Artificial | 3 | 2023 | 817 | 0.860 |
Why?
|
Retrospective Studies | 54 | 2024 | 77098 | 0.840 |
Why?
|
Elephants | 1 | 2022 | 36 | 0.830 |
Why?
|
Stroke | 16 | 2023 | 9963 | 0.800 |
Why?
|
Shock, Cardiogenic | 5 | 2023 | 684 | 0.790 |
Why?
|
Venous Thrombosis | 4 | 2021 | 1237 | 0.790 |
Why?
|
Peptide Fragments | 5 | 2020 | 5095 | 0.780 |
Why?
|
Expert Testimony | 1 | 2024 | 356 | 0.780 |
Why?
|
Hyperpigmentation | 5 | 2021 | 112 | 0.740 |
Why?
|
Venous Thromboembolism | 5 | 2021 | 1668 | 0.740 |
Why?
|
Hirudins | 3 | 2017 | 182 | 0.740 |
Why?
|
Vena Cava Filters | 4 | 2021 | 252 | 0.730 |
Why?
|
Thrombolytic Therapy | 10 | 2024 | 2161 | 0.720 |
Why?
|
HIV Infections | 12 | 2023 | 16678 | 0.700 |
Why?
|
Patient Discharge | 8 | 2024 | 3300 | 0.700 |
Why?
|
Angioplasty | 2 | 2019 | 364 | 0.690 |
Why?
|
Thrombectomy | 3 | 2023 | 679 | 0.660 |
Why?
|
Time Factors | 37 | 2022 | 40054 | 0.660 |
Why?
|
Defibrillators, Implantable | 3 | 2023 | 1440 | 0.660 |
Why?
|
Coronary Angiography | 11 | 2024 | 4567 | 0.660 |
Why?
|
Vascular Diseases | 2 | 2024 | 1155 | 0.630 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 882 | 0.620 |
Why?
|
Angiography | 2 | 2022 | 1636 | 0.600 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 154 | 0.590 |
Why?
|
Aspirin | 4 | 2023 | 3278 | 0.590 |
Why?
|
Angina Pectoris | 3 | 2022 | 977 | 0.590 |
Why?
|
Antithrombins | 2 | 2017 | 304 | 0.590 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5019 | 0.590 |
Why?
|
Male | 90 | 2023 | 349538 | 0.580 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2023 | 685 | 0.580 |
Why?
|
Heart Rate | 3 | 2015 | 4091 | 0.580 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1181 | 0.570 |
Why?
|
Female | 95 | 2023 | 379592 | 0.560 |
Why?
|
Acute Disease | 9 | 2023 | 7141 | 0.540 |
Why?
|
Mortality | 4 | 2021 | 2857 | 0.530 |
Why?
|
Ticlopidine | 3 | 2019 | 899 | 0.520 |
Why?
|
Risk Assessment | 23 | 2024 | 23320 | 0.510 |
Why?
|
Coronary Stenosis | 1 | 2021 | 834 | 0.500 |
Why?
|
Heart Failure, Diastolic | 1 | 2015 | 69 | 0.490 |
Why?
|
Propensity Score | 4 | 2021 | 1771 | 0.490 |
Why?
|
Inpatients | 5 | 2024 | 2495 | 0.480 |
Why?
|
Pneumonia | 2 | 2023 | 2117 | 0.470 |
Why?
|
Patient Selection | 2 | 2023 | 4214 | 0.470 |
Why?
|
Aged, 80 and over | 27 | 2023 | 57683 | 0.460 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 656 | 0.450 |
Why?
|
Myocardial Revascularization | 1 | 2017 | 841 | 0.450 |
Why?
|
Heparin | 2 | 2017 | 1636 | 0.430 |
Why?
|
Heart Failure | 6 | 2021 | 10856 | 0.430 |
Why?
|
Middle Aged | 55 | 2021 | 213127 | 0.420 |
Why?
|
Health Status Disparities | 2 | 2020 | 1794 | 0.410 |
Why?
|
Fibrinolytic Agents | 4 | 2023 | 2156 | 0.410 |
Why?
|
Brain Ischemia | 2 | 2017 | 3258 | 0.410 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 548 | 0.400 |
Why?
|
Antineoplastic Agents, Phytogenic | 5 | 2021 | 623 | 0.390 |
Why?
|
Drug Therapy, Combination | 9 | 2023 | 6483 | 0.390 |
Why?
|
Prospective Studies | 20 | 2023 | 53187 | 0.390 |
Why?
|
Hospitalization | 9 | 2022 | 10232 | 0.390 |
Why?
|
Embolectomy | 2 | 2023 | 120 | 0.380 |
Why?
|
Quality of Life | 9 | 2023 | 12730 | 0.380 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1499 | 0.370 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1527 | 0.370 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2195 | 0.360 |
Why?
|
Incidence | 14 | 2023 | 20928 | 0.360 |
Why?
|
Heart Diseases | 1 | 2023 | 2789 | 0.360 |
Why?
|
Sunscreening Agents | 3 | 2019 | 132 | 0.360 |
Why?
|
Electrocardiography | 2 | 2015 | 6440 | 0.350 |
Why?
|
Hypertension | 3 | 2023 | 8455 | 0.350 |
Why?
|
Vasoconstrictor Agents | 2 | 2019 | 643 | 0.340 |
Why?
|
Ischemic Attack, Transient | 1 | 2015 | 934 | 0.340 |
Why?
|
Beauty | 2 | 2020 | 42 | 0.340 |
Why?
|
Arteries | 3 | 2023 | 1118 | 0.340 |
Why?
|
Death, Sudden, Cardiac | 3 | 2014 | 1541 | 0.330 |
Why?
|
Databases, Factual | 7 | 2022 | 7716 | 0.330 |
Why?
|
Pyridines | 2 | 2017 | 2818 | 0.320 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1573 | 0.320 |
Why?
|
Sunburn | 2 | 2019 | 155 | 0.310 |
Why?
|
Arterial Occlusive Diseases | 2 | 2023 | 793 | 0.310 |
Why?
|
Odds Ratio | 7 | 2022 | 9846 | 0.300 |
Why?
|
Sirolimus | 3 | 2022 | 1562 | 0.300 |
Why?
|
Chronic Disease | 11 | 2024 | 9144 | 0.290 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2145 | 0.280 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5724 | 0.280 |
Why?
|
Cocaine | 1 | 2011 | 1008 | 0.270 |
Why?
|
Prosthesis Design | 3 | 2023 | 2110 | 0.270 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2867 | 0.270 |
Why?
|
Skin Pigmentation | 2 | 2018 | 281 | 0.270 |
Why?
|
Autonomic Nervous System | 1 | 2010 | 671 | 0.270 |
Why?
|
Cardiology | 4 | 2021 | 1658 | 0.260 |
Why?
|
Heart Conduction System | 1 | 2010 | 1048 | 0.250 |
Why?
|
Patient Transfer | 1 | 2011 | 760 | 0.250 |
Why?
|
Consensus | 3 | 2023 | 2935 | 0.250 |
Why?
|
Death, Sudden | 2 | 2018 | 298 | 0.240 |
Why?
|
Postoperative Complications | 4 | 2023 | 15244 | 0.240 |
Why?
|
Arrhythmias, Cardiac | 2 | 2011 | 2267 | 0.240 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1873 | 0.240 |
Why?
|
Comorbidity | 4 | 2020 | 10372 | 0.240 |
Why?
|
Ultrasonography | 5 | 2024 | 5978 | 0.240 |
Why?
|
Heart-Assist Devices | 2 | 2023 | 1194 | 0.220 |
Why?
|
Aftercare | 3 | 2023 | 860 | 0.210 |
Why?
|
Tubulin Modulators | 2 | 2020 | 110 | 0.210 |
Why?
|
Vascular System Injuries | 2 | 2023 | 250 | 0.210 |
Why?
|
Raynaud Disease | 1 | 2022 | 67 | 0.210 |
Why?
|
HIV | 2 | 2023 | 1600 | 0.200 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12344 | 0.200 |
Why?
|
Blood Pressure | 2 | 2021 | 8541 | 0.200 |
Why?
|
Skin Diseases | 2 | 2022 | 1065 | 0.200 |
Why?
|
Renal Dialysis | 1 | 2010 | 1780 | 0.200 |
Why?
|
Shock | 1 | 2023 | 318 | 0.200 |
Why?
|
Sympathectomy | 1 | 2021 | 89 | 0.190 |
Why?
|
Punctures | 2 | 2020 | 372 | 0.190 |
Why?
|
Sex Factors | 5 | 2021 | 10392 | 0.190 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 42 | 0.190 |
Why?
|
Melanosis | 1 | 2021 | 78 | 0.180 |
Why?
|
Pulmonary Edema | 1 | 2023 | 415 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 4 | 2021 | 6534 | 0.170 |
Why?
|
Esthetics | 2 | 2018 | 306 | 0.170 |
Why?
|
Length of Stay | 5 | 2020 | 6294 | 0.170 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 86 | 0.170 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2020 | 132 | 0.170 |
Why?
|
Myocardial Reperfusion | 1 | 2020 | 351 | 0.170 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2023 | 430 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 9941 | 0.170 |
Why?
|
Veterans Health | 1 | 2021 | 216 | 0.170 |
Why?
|
Recombinant Proteins | 3 | 2017 | 6608 | 0.170 |
Why?
|
Peripheral Vascular Diseases | 1 | 2022 | 550 | 0.170 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 1941 | 0.160 |
Why?
|
Protective Devices | 1 | 2018 | 71 | 0.160 |
Why?
|
Chemexfoliation | 1 | 2018 | 11 | 0.160 |
Why?
|
Aerospace Medicine | 1 | 2018 | 80 | 0.160 |
Why?
|
Veterans | 2 | 2023 | 2513 | 0.160 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2275 | 0.160 |
Why?
|
Learning Curve | 1 | 2019 | 200 | 0.160 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2536 | 0.160 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 933 | 0.160 |
Why?
|
Habits | 1 | 2018 | 137 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 246 | 0.160 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 453 | 0.160 |
Why?
|
Cohort Studies | 9 | 2023 | 40450 | 0.160 |
Why?
|
Environment, Controlled | 1 | 2017 | 46 | 0.150 |
Why?
|
Constriction, Pathologic | 4 | 2023 | 1095 | 0.150 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39004 | 0.150 |
Why?
|
Dermatology | 2 | 2018 | 870 | 0.150 |
Why?
|
Quality Improvement | 3 | 2022 | 3738 | 0.150 |
Why?
|
Chemoprevention | 1 | 2020 | 319 | 0.150 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2043 | 0.150 |
Why?
|
Survival Rate | 5 | 2020 | 12773 | 0.150 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1402 | 0.150 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.150 |
Why?
|
Adult | 27 | 2024 | 213712 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 361 | 0.140 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2021 | 501 | 0.140 |
Why?
|
Sunlight | 1 | 2018 | 325 | 0.140 |
Why?
|
Equipment Design | 3 | 2020 | 3582 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 604 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 3915 | 0.140 |
Why?
|
Erythema | 1 | 2018 | 254 | 0.140 |
Why?
|
Color Perception | 1 | 2017 | 213 | 0.140 |
Why?
|
Absorbable Implants | 1 | 2019 | 342 | 0.140 |
Why?
|
Communication Barriers | 1 | 2019 | 398 | 0.140 |
Why?
|
Lasers | 1 | 2020 | 952 | 0.140 |
Why?
|
Sickness Impact Profile | 1 | 2017 | 304 | 0.140 |
Why?
|
Brachial Artery | 1 | 2017 | 370 | 0.140 |
Why?
|
Hospital Costs | 2 | 2019 | 980 | 0.130 |
Why?
|
Cause of Death | 4 | 2023 | 3571 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19862 | 0.130 |
Why?
|
Conscious Sedation | 1 | 2020 | 528 | 0.130 |
Why?
|
Drug Utilization Review | 1 | 2016 | 245 | 0.130 |
Why?
|
Radial Artery | 1 | 2017 | 194 | 0.130 |
Why?
|
Reminder Systems | 1 | 2018 | 370 | 0.130 |
Why?
|
Choice Behavior | 1 | 2021 | 802 | 0.130 |
Why?
|
Malnutrition | 1 | 2022 | 625 | 0.130 |
Why?
|
Social Class | 2 | 2021 | 1995 | 0.130 |
Why?
|
Hemostatic Techniques | 1 | 2016 | 116 | 0.130 |
Why?
|
Coronary Vessels | 4 | 2022 | 3099 | 0.130 |
Why?
|
Body Image | 1 | 2020 | 609 | 0.130 |
Why?
|
Outpatients | 2 | 2019 | 1483 | 0.130 |
Why?
|
Seasons | 2 | 2018 | 1492 | 0.130 |
Why?
|
Object Attachment | 1 | 2017 | 313 | 0.120 |
Why?
|
Ankle | 1 | 2017 | 327 | 0.120 |
Why?
|
Exercise Therapy | 1 | 2021 | 904 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.120 |
Why?
|
Risk Adjustment | 1 | 2018 | 594 | 0.120 |
Why?
|
Walking | 1 | 2021 | 1177 | 0.120 |
Why?
|
Metals | 1 | 2018 | 717 | 0.120 |
Why?
|
Research Design | 2 | 2021 | 5979 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1181 | 0.120 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 24913 | 0.120 |
Why?
|
Cost Savings | 1 | 2019 | 925 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15056 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 865 | 0.110 |
Why?
|
Device Removal | 1 | 2018 | 652 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2020 | 1520 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15530 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2020 | 1164 | 0.110 |
Why?
|
Natriuretic Peptides | 1 | 2014 | 150 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4929 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1737 | 0.110 |
Why?
|
Social Responsibility | 1 | 2015 | 389 | 0.100 |
Why?
|
Pyridones | 1 | 2016 | 712 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15108 | 0.100 |
Why?
|
Polymers | 1 | 2019 | 1618 | 0.100 |
Why?
|
Logistic Models | 4 | 2024 | 13403 | 0.100 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 681 | 0.100 |
Why?
|
Chest Pain | 1 | 2018 | 1113 | 0.100 |
Why?
|
Drug Costs | 1 | 2019 | 1104 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1196 | 0.100 |
Why?
|
Light | 1 | 2017 | 1374 | 0.100 |
Why?
|
Affect | 1 | 2019 | 1473 | 0.100 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2714 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1527 | 0.100 |
Why?
|
Freedom | 2 | 2021 | 69 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1484 | 0.090 |
Why?
|
HIV Protease Inhibitors | 1 | 2012 | 430 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3302 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5662 | 0.090 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 236 | 0.090 |
Why?
|
Prognosis | 5 | 2021 | 29010 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2018 | 12017 | 0.090 |
Why?
|
Recurrence | 1 | 2021 | 8333 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1348 | 0.090 |
Why?
|
Calcium | 1 | 2022 | 5753 | 0.080 |
Why?
|
Echocardiography | 3 | 2020 | 5097 | 0.080 |
Why?
|
Disclosure | 1 | 2015 | 736 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2781 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2527 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3937 | 0.080 |
Why?
|
Thoracic Surgery | 1 | 2015 | 713 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2281 | 0.080 |
Why?
|
Skin | 2 | 2022 | 4353 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1967 | 0.080 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.080 |
Why?
|
Reference Values | 1 | 2015 | 4982 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2010 | 585 | 0.080 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 2337 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2019 | 1895 | 0.080 |
Why?
|
United States Department of Veterans Affairs | 2 | 2023 | 874 | 0.080 |
Why?
|
Health Expenditures | 1 | 2020 | 2346 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3527 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3014 | 0.070 |
Why?
|
Mitral Valve | 1 | 2015 | 1484 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2493 | 0.070 |
Why?
|
Pyrazoles | 1 | 2016 | 1970 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2400 | 0.070 |
Why?
|
Dyspnea | 1 | 2014 | 1298 | 0.070 |
Why?
|
Smoking | 2 | 2020 | 8969 | 0.070 |
Why?
|
Medicaid | 1 | 2019 | 2716 | 0.070 |
Why?
|
New York | 2 | 2019 | 886 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7167 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2011 | 741 | 0.060 |
Why?
|
RNA, Viral | 1 | 2014 | 2899 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13921 | 0.060 |
Why?
|
Age Factors | 5 | 2021 | 18355 | 0.060 |
Why?
|
Viral Load | 1 | 2014 | 3292 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3239 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4566 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2211 | 0.060 |
Why?
|
Postpartum Period | 2 | 2021 | 1078 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7645 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 85649 | 0.060 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 854 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4681 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1780 | 0.060 |
Why?
|
Weight Gain | 1 | 2014 | 2282 | 0.060 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2014 | 2059 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 7010 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3306 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4147 | 0.050 |
Why?
|
Dinucleoside Phosphates | 1 | 2022 | 74 | 0.050 |
Why?
|
Hemoptysis | 1 | 2023 | 155 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5462 | 0.050 |
Why?
|
Hydroquinones | 1 | 2021 | 36 | 0.050 |
Why?
|
Nitroglycerin | 1 | 2022 | 325 | 0.050 |
Why?
|
Delphi Technique | 1 | 2023 | 778 | 0.050 |
Why?
|
Young Adult | 7 | 2021 | 56350 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16331 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5304 | 0.050 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2637 | 0.050 |
Why?
|
New Zealand | 1 | 2020 | 357 | 0.040 |
Why?
|
Disease Management | 2 | 2021 | 2450 | 0.040 |
Why?
|
Premedication | 1 | 2020 | 257 | 0.040 |
Why?
|
Depression | 1 | 2019 | 7733 | 0.040 |
Why?
|
Accidents, Aviation | 1 | 2018 | 14 | 0.040 |
Why?
|
Prevalence | 2 | 2019 | 15194 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 294 | 0.040 |
Why?
|
Wit and Humor as Topic | 1 | 2018 | 31 | 0.040 |
Why?
|
Edema | 1 | 2023 | 790 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2020 | 517 | 0.040 |
Why?
|
Prescriptions | 1 | 2021 | 387 | 0.040 |
Why?
|
Body Fat Distribution | 1 | 2020 | 244 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 350 | 0.040 |
Why?
|
Sunbathing | 1 | 2018 | 60 | 0.040 |
Why?
|
Aircraft | 1 | 2018 | 123 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2021 | 1952 | 0.040 |
Why?
|
Data Collection | 2 | 2019 | 3339 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 846 | 0.040 |
Why?
|
Florida | 1 | 2019 | 435 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2023 | 865 | 0.040 |
Why?
|
Facial Dermatoses | 1 | 2018 | 87 | 0.040 |
Why?
|
Veins | 1 | 2022 | 769 | 0.040 |
Why?
|
Hematoma | 1 | 2022 | 755 | 0.040 |
Why?
|
Skin Aging | 1 | 2018 | 127 | 0.040 |
Why?
|
Health Status | 2 | 2022 | 4030 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1167 | 0.040 |
Why?
|
Critical Illness | 2 | 2020 | 2665 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2018 | 127 | 0.040 |
Why?
|
Health Care Costs | 2 | 2021 | 3203 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 221 | 0.040 |
Why?
|
American Heart Association | 1 | 2021 | 1055 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1342 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1215 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2061 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1343 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 685 | 0.030 |
Why?
|
Markov Chains | 1 | 2019 | 969 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1013 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 2018 | 436 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 764 | 0.030 |
Why?
|
Photography | 1 | 2018 | 521 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 565 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1002 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 713 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 578 | 0.030 |
Why?
|
Comprehension | 1 | 2020 | 608 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13256 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1911 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1110 | 0.030 |
Why?
|
India | 1 | 2020 | 2187 | 0.030 |
Why?
|
San Francisco | 1 | 2014 | 159 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 519 | 0.030 |
Why?
|
California | 1 | 2017 | 1400 | 0.030 |
Why?
|
Workload | 1 | 2019 | 849 | 0.030 |
Why?
|
Troponin T | 1 | 2018 | 749 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2303 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1679 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2167 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1314 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1499 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1130 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2533 | 0.030 |
Why?
|
Sex Distribution | 1 | 2017 | 2295 | 0.030 |
Why?
|
Algorithms | 2 | 2023 | 13853 | 0.030 |
Why?
|
Morbidity | 1 | 2017 | 1767 | 0.030 |
Why?
|
Aortic Valve | 1 | 2021 | 1911 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3510 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2485 | 0.020 |
Why?
|
Animals | 1 | 2022 | 168561 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 2 | 2015 | 3526 | 0.020 |
Why?
|
Heart Arrest | 1 | 2019 | 1469 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29087 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1533 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2566 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10248 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3801 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3507 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9305 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2739 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2838 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2630 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1431 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5385 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3766 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4440 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3062 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5948 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7901 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2019 | 4369 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12242 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8328 | 0.010 |
Why?
|
Stroke Volume | 1 | 2014 | 4983 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 40955 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.010 |
Why?
|